Publications by authors named "Kenneth F May"

Claim this Profile
A
Antibody-mediated inhibition of MICA and MICB shedding promotes NK cell-driven tumor immunity.
Lucas Ferrari de Andrade, Rong En Tay, Deng Pan, Adrienne M Luoma, Yoshinaga Ito, Kenneth F May

Science· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostate cancer immunotherapy.
Kenneth F May, James L Gulley, Charles G Drake, Glenn Dranoff, Philip W Kantoff

Clin Cancer Res· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ex vivo characterization and isolation of rare memory B cells with antigen tetramers.
Bettina Franz, Kenneth F May, Glenn Dranoff, Kai Wucherpfennig

Blood· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
B7-deficient autoreactive T cells are highly susceptible to suppression by CD4(+)CD25(+) regulatory T cells.
Kenneth F May, Xing Chang, Huiming Zhang, Kenneth D Lute, Penghui Zhou

J Immunol· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune competence of cancer-reactive T cells generated de novo in adult tumor-bearing mice.
Kenneth F May, Kenneth Lute, Ergun Kocak, Shahab Abdessalam, Lijie Yin

Blood· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination therapy with anti-CTL antigen-4 and anti-4-1BB antibodies enhances cancer immunity and reduces autoimmunity.
Ergun Kocak, Kenneth Lute, Xing Chang, Kenneth F May, Katie R Exten

Cancer Res· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human CTLA4 knock-in mice unravel the quantitative link between tumor immunity and autoimmunity induced by anti-CTLA-4 antibodies.
Kenneth D Lute, Kenneth F May, Ping Lu, Huiming Zhang, Ergun Kocak

Blood· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-human CTLA-4 monoclonal antibody promotes T-cell expansion and immunity in a hu-PBL-SCID model: a new method for preclinical screening of costimulatory monoclonal antibodies.
Kenneth F May, Sameek Roychowdhury, Darshna Bhatt, Ergun Kocak, Xue-Feng Bai

Blood· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Failed adoptive immunotherapy with tumor-specific T cells: reversal with low-dose interleukin 15 but not low-dose interleukin 2.
Sameek Roychowdhury, Kenneth F May, Katherine S Tzou, Teresa Lin, Darshna Bhatt

Cancer Res· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
On the role of unmutated antigens in tumor rejection in mice with unperturbed T-cell repertoires.
Supria Sarma, Xue-Feng Bai, Jin-qing Liu, Kenneth F May, Pan Zheng

Cancer Res· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-4-1BB monoclonal antibody enhances rejection of large tumor burden by promoting survival but not clonal expansion of tumor-specific CD8+ T cells.
Kenneth F May, Lieping Chen, Pan Zheng, Yang Liu

Cancer Res· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
B7-CTLA4 interaction promotes cognate destruction of tumor cells by cytotoxic T lymphocytes in vivo.
Xue-Feng Bai, Jinqing Liu, Kenneth F May, Yong Guo, Pan Zheng

Blood· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis